ArticleVeterinary research communications2026
Long-term supplementation of exogenous bile acids enhanced growth efficacy, hematology, non-specific immunity, and intestinal histomorphology, with significant liver dysfunction in Nile tilapia fingerlings.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 16-week feeding trial was conducted to examine the effects of dietary exogenous bile acids (BAs) on growth performance, digestive enzyme activities, biochemical indices, antioxidant capacity, non-specific immune response, gene expression of proinflammatory cytokines, and liver and intestinal morphology in Nile tilapia (initial weight, 5.10 ± 0.22 g) reared in earthen ponds over an extended period. Two isonitrogenous (31.65% protein) and isolipidic (4.71%) experimental diets were formulated by adding a control diet (BA0) and 0.25 g bile acid per kg diet (BA0.25), respectively. The diets were randomly assigned to 6 hapas, each stocked with 20 fish and fed for 16 weeks. Supplementing with BA0.25 significantly enhanced growth metrics and intestinal digestive enzyme activities compared to BA0. Hematological analysis showed increased levels of white blood cells (WBC), lymphocytes, and neutrophils in the BA0.25 group compared to the control. Additionally, respiratory burst activity, phagocytic activity, and serum lysozyme activity were notably higher in fish fed BAs at 0.25 g kg− 1. Antioxidant parameters (SOD, CAT, GSH) were elevated, and the expression of the proinflammatory cytokine IL1β was downregulated in intestinal tissue from the BAs-supplemented group. Significant improvements in intestinal histomorphometry were observed in the BAs-supplemented group. BAs supplementation altered intestinal microbial composition, increasing total and Pseudomonas counts while reducing coliform levels. Interestingly, glucose, triglycerides, cholesterol, serum hepatic markers (ALT, AST, and ALP), hepatic oxidative MDA levels, and proinflammatory IL1β mRNA expression increased markedly in the supplemented-BAs group, while activity of antioxidant enzymes (SOD, CAT, GSH) and HSP70 mRNA expression were notably diminished. Moreover, significant alterations were shown in the hepatic tissue of the BAs-supplemented group. Consequently, dietary supplementation with bile acids for a prolonged period improves growth, intestinal health, and immunity; however, it harms the liver health of Nile tilapia.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.